Pretoria to Cape Town via the Garden Route
1800km
15 cyclists consisting of cancer survivors and cancer fighters
26 February to 9 March 2007
Cancer is a disease that affects us all. Millions of people are diagnosed with cancer every year but knowing and recognizing the warning signs and obtaining prompt medical attention can save lives.
The "Ride for Hope - Balekela Ethembeni" campaign is a partnership between CANSA, NTP Radioisotopes (Pty) Ltd & its parent organisation NECSA, with the main aim of highlighting the necessity for South Africans to lead a healthy and active lifestyle in order to minimise the probability of becoming victims of cancer. Simultaneously the aim is also to show that the disease can be detected and treated (especially using nuclear medical technology) and that survival is a real and increasingly likely prognosis for sufferers.
CANSA North West, is a registered Non-Profit Organisation (NPO 000-524) whose mission is to substantially reduce the impact of cancer by promoting health in all communities within South Africa, through advocacy and the sustainable facilitation of research, prevention, early detection and care. Cansa has representation and support structures (including fundraising and publicity expertise and resources) in most town and cities in South Africa. For more information please visit www.cansa.org.za.
NTP Radioisotopes Pty (Ltd) produces and markets internationally a range of products that are used for diagnostic imaging, most notably for the reliable and accurate diagnosis and staging of cancers as well as for monitoring and assessing the impact of therapeutic interventions. NTP's corporate objective is to provide products and services that “Actively enhance life” and issues relating to cancer treatment and diagnosis are therefore a focus of its Corporate Social Investment Programme. For more information please visit www.ntp.co.za
NECSA (South African Nuclear Energy Corporation) is NTP's parent organisation and is the national organisation tasked with developing and utilising nuclear technology and facilities that promote and support the many beneficial applications of the peaceful use of this technology. NECSA owns and operates the world-renowned SAFARI-1 nuclear reactor that is used as a critical input to the production of radioisotopes by NTP. Nuclear medicines produced by NTP with the help of SAFARI-1 and its technologists is used globally in over 2,5 million diagnostic medical procedures every year, many of these involving cancers and many of which are life-saving.
For more information please visit www.necsa.co.za
